If a patient with hypertension is prescribed a drug that inhibits the action of aldosterone in the kidneys, which consequence follows?

💡 Explanation

Aldosterone promotes sodium reabsorption in the kidneys. Therefore, inhibiting aldosterone decreases sodium reabsorption in the kidney tubules, because the mineralocorticoid receptor is blocked, rather than promoting sodium retention or directly impacting potassium excretion or angiotensin II production.

• If an individual experiences a sudden drop in blood volume due to hemorrhage, which physiological consequence occurs?
• If a patient exhibits severe muscle weakness and neurological dysfunction despite adequate protein intake, which cofactor-related deficiency is the MOST likely underlying cause?
• Which failure increases risk of osmotic demyelination following rapid hyponatremia correction?
• Why does increasing renal blood flow within physiological limits enhance drug clearance, assuming glomerular filtration is the primary elimination pathway?
• Why does performance on cognitive tasks requiring memorization suffer more after sleep deprivation compared to tasks requiring simple reaction time?
• Why does the effectiveness of tPA, a thrombolytic drug for ischemic stroke, diminish significantly after the initial hours following symptom onset?